Atlas Trials

Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT

Clinical trial NCT02779959 · UNKNOWN

Trial details

NCT number
NCT02779959
Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Migraine Disorders
Start date
2016-04-01
Primary completion
2017-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.